Inventor · disambiguated record
Mark Moore
Also filed as: MOORE MARK · MOORE MARK D
5 granted patents·25 pending applications·91 citations·filing 1992–2024
81Inventor score
Files withALLEN KEITH D4BRENNAN THOMAS J4LIFE EDIT THERAPEUTICS INC2LIFEEDIT THERAPEUTICS INC2DELTAGEN INC1
Top patents by PatentIndex Score
30 records- 0188US6909031B2Transgenic mice containing glucagon receptor gene disruptionsDELTAGEN INC·Filed 2001·Granted Jun 21, 2005·24 cites·7 claims
- 0288US2025092398A1Polypeptides useful for gene editing and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0387US2025066783A1Polypeptides useful for gene editing and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0485US12188018B2Polypeptides useful for gene editing and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2023·Granted Jan 7, 2025·0 cites·28 claims
- 0576US6248724B1Antisense oligonucleotide compositions targeted to angiotensin converting enzyme MRNA and methods of useUNIV FLORIDA·Filed 1998·Granted Jun 19, 2001·51 cites·59 claims
- 0672US2022145296A1Polypeptides useful for gene editing and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0763US5352608ABioreduction of metal oxides and oxyanions by photosynthetic bacteriaUNIV TEXAS·Filed 1992·Granted Oct 4, 1994·10 cites·26 claims
- 0855US5804424AProcess for the production of hydrogen using photosynthetic proteobacteriaFiled 1993·Granted Sep 8, 1998·6 cites·32 claims
- 0954US2003121066A1Transgenic mice containing SOCS-5 cytokine signalling suppressor gene disruptionsFiled 2002·Application pending·0 cites
- 1051US2007074299A1Transgenic Mice Containing GPCR5-1 Gene DisruptionsBRENNAN THOMAS J·Filed 2006·Application pending·0 cites
- 1150US2002177134A1Transgenic mice containing PAFR gene disruptionsFiled 2001·Application pending·0 cites
- 1250US2006143722A1OGR1 gene disruptions, compositions and methods relating theretoBRENNAN THOMAS J·Filed 2006·Application pending·0 cites
- 1349US2006174361A1Transgenic mice containing adrenocorticotropin hormone receptor gene disruptionsALLEN KEITH D·Filed 2006·Application pending·0 cites
- 1449US2006075512A1Transgenic mice containing PAFR gene disruptionsBRENNAN THOMAS J·Filed 2005·Application pending·0 cites
- 1549US2006185028A1Transgenic mice containing SOCS-5 cytokine signalling suppressor gene disruptionsALLEN KEITH D·Filed 2006·Application pending·0 cites
- 1647US2003005473A1OGR1 gene disruptions, compositions and methods relating theretoFiled 2002·Application pending·0 cites
- 1747US2002170081A1Transgenic mice containing GPR31 gene disruptionsFiled 2002·Application pending·0 cites
- 1847US2003018989A1Transgenic mice containing GPCR5-1 gene disruptionsFiled 2002·Application pending·0 cites
- 1945US2006143724A1Transgenic mice containing anaphylatoxin C3a gene disruptionsBRENNAN THOMAS J·Filed 2006·Application pending·0 cites
- 2045US2002133843A1Transgenic mice containing adrenocorticotropin hormone receptor gene disruptionsFiled 2001·Application pending·0 cites
- 2145US2002127712A1Transgenic mice containing anaphylatoxin C3a gene disruptionsFiled 2001·Application pending·0 cites
- 2245US2021172008A1Methods and compositions to identify novel crispr systemsLIFEEDIT INC·Filed 2019·Application pending·0 cites
- 2344US2006156426A1Transgenic mice containing ABC transporter-like ATPase gene disruptionsALLEN KEITH D·Filed 2006·Application pending·0 cites
- 2444US2003014769A1Transgenic mice containing GPCR-like transmembrane protein disruptionsFiled 2002·Application pending·0 cites
- 2542US2006172413A1Transgenic mice containing melanocyte stimulating hormone receptor gene disruptionsALLEN KEITH D·Filed 2006·Application pending·0 cites
- 2642US2002120951A1Transgenic mice containing FPR-RS4 gene disruptionsFiled 2001·Application pending·0 cites
- 2742US2003106073A1Transgenic mice containing FPR-RS4 gene disruptionsFiled 2001·Application pending·0 cites
- 2842US2003167493A1Transgenic mice containing GPRC5B-like gene disruptionsFiled 2001·Application pending·0 cites
- 2941US2002088012A1Transgenic mice containing lymphoid-specific GPCR gene disruptionsFiled 2001·Application pending·0 cites
- 3039US2002038467A1Transgenic mice containing melanocyte stimulating hormone receptor gene disruptionsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Moore files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →